Advertisment
EuLITE: high cut-off haemodialysis doesn’t improve outcomes in myeloma cast nephropathy. Dr Mark Cook (University Hospitals Birmingham, UK) discusses the results of the EuLITE trial looking at free light chain removal by extended haemodialysis in cast nephropathy.
